AI assistant
CYTOKINETICS INC — Director's Dealing 2013
May 29, 2013
30870_dirs_2013-05-29_bf1e4239-528a-4635-9a3e-988d7da9b782.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2013-05-22
Reporting Person: COSTA SANTO J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-22 | Non-Qualified Stock Option (right to buy) | $1.13 | A | 25000 | Acquired | 2023-05-22 | Common Stock (25000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $0.91 | 2022-05-22 | Common Stock (25000) | 25000 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.44 | 2021-05-18 | Common Stock (20000) | 20000 | Direct |
| Non-Qualified Stock Option (right to buy) | $2.54 | 2020-11-01 | Common Stock (40000) | 40000 | Direct |
Footnotes
F1: This option shall vest and become exercisable as to 25,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 22, 2014.
F2: This option shall vest and become exercisable as to 25,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 22, 2013.
F3: This option shall vest and become exercisable as to 20,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 18, 2012.
F4: This option shall vest and become exercisable as to 40,000 shares divided into equal monthly installments such that the option shall be 100% vested on November 1, 2013.